Core Viewpoint - Suzhou Tianwo Technology Co., Ltd. is involved in a legal dispute regarding a compensation agreement related to the actual net profit of its subsidiary, Zhongji Guoneng Power Engineering Co., Ltd., with a claimed compensation amount of 1.804 billion yuan [1][2]. Group 1: Litigation Details - The company has filed a lawsuit against multiple parties for compensation due to discrepancies in profit forecasts and actual performance [1][2]. - The lawsuit has progressed to a point where the court has issued a final ruling, confirming the validity of the initial judgment [2]. - The company has received a partial payment of approximately 710.71 million yuan from the defendants prior to the final ruling [2]. Group 2: Financial Implications - The company has recognized a receivable balance of 1.757 billion yuan related to the compensation claim, with a provision for bad debts already accounted for [3][4]. - There remains uncertainty regarding the collection of the compensation amount, despite the court ruling being effective [3][4]. - The company will continue to monitor the situation and fulfill its disclosure obligations as required by accounting standards [4].

证券代码：002564 证券简称：天沃科技 公告编号：2025-039 苏州天沃科技股份有限公司 重大诉讼、仲裁情况的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1．案件所处的诉讼、仲裁阶段：已结案 2．上市公司所处的当事人地位：原告 3．涉案金额：1,804,000,000.00 元 4．对上市公司损益产生的影响：目前暂时无法判断对公司本期利润和期后 利润的影响。 证券代码：002564 证券简称：天沃科技 公告编号：2025-039 1．原告：苏州天沃科技股份有限公司 5．本次业绩补偿诉讼案件判决结果虽已生效，但公司能否收到相应款项仍 存在不确定性，并于 2023 年末即已就相应款项计提减值。敬请广大投资者理性 投资，注意投资风险。 苏州天沃科技股份有限公司（下称"公司"）前期与相关方（下称"业绩承诺 方"）签署了《标的资产实际净利润数与净利润预测数差额的补偿协议书》（下 称"《补偿协议书》"）。综合公司原下属子公司中机国能电力工程有限公司（下 称"中机电力"）经追溯调整后的业绩实现情况，以及中机电力于 2019 年末的股 权减值 ...

New Stock Issuance - Multiple companies are scheduled for new stock issuance on July 24, 2025, including *ST Zitian (300280) and ST Nanzhi (002305) [1] - Significant announcements were made for companies like Guosheng Tang (300436) and Huayin Power (600744) on July 17 and July 15, respectively [1] Trading Alerts - Companies such as Gaoguan Min Explosive (002827) and Zhongyan Dadi (003001) have recent trading alerts as of July 24, 2025 [1] - A total of 50 companies have been flagged for abnormal trading fluctuations, indicating potential market volatility [2] Market Trends - The report highlights a trend of increased market activity with numerous companies announcing significant changes in stock status [1] - The presence of multiple *ST (Special Treatment) companies suggests heightened scrutiny and potential risk for investors [1] Regulatory Compliance - Companies are required to disclose significant announcements to ensure transparency in trading activities [1] - The report emphasizes the importance of monitoring announcements to assess market conditions and investment risks [1]

Group 1 - The company's stock price experienced an abnormal fluctuation, with a cumulative increase of over 20% in closing prices over three consecutive trading days (July 10, July 11, and July 14, 2025) [1] - The company conducted an investigation regarding the abnormal stock price movement and confirmed that there are no undisclosed significant information or major matters under planning that could impact the stock price [1] - The board of directors confirmed that there are no undisclosed matters that should be disclosed according to the Shenzhen Stock Exchange regulations, nor any information that could significantly affect the company's stock and its derivatives [1]

股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 证券代码：002564 证券简称：天沃科技 公告编号：2025-038 苏州天沃科技股份有限公司 5. 股票异常波动期间未发生公司控股股东、实际控制人买卖公司股票的行 为。 三、是否存在应披露而未披露信息的说明 本公司董事会确认，本公司目前没有任何根据《深圳证券交易所股票上市规 则》等有关规定应予以披露而未披露的事项或与该事项有关的筹划、商谈、意向、 协议等；董事会也未获悉本公司有根据《深圳证券交易所股票上市规则》等有关 规定应予以披露而未披露的、对本公司股票及其衍生品种交易价格产生较大影响 的信息；公司前期披露的信息不存在需要更正、补充之处。 一、股票交易异常波动的情况介绍 公司股票交易价格连续三个交易日（2025 年 7 月 10 日、7 月 11 日、7 月 14 日）收盘价格涨幅偏离值累计超过 20%，根据深圳证券交易所的有关规定，属于 股票交易异常波动的情况。 二、公司关注、核实情况说明 针对公司股票交易异常波动，公司对有关事项进行了核查，有关情况说明如 下： 1. 公司前期披露的 ...

Group 1 - The company expects a net loss for the period from January 1, 2025, to June 30, 2025, with a projected loss of 7.4 million to 11 million yuan, compared to a profit of 15.5 million yuan in the same period last year [1] - The net profit attributable to shareholders, after deducting non-recurring gains and losses, is expected to be a loss of 29.27 million yuan, while the profit is projected to be between 1.35 million and 2 million yuan [1] - The basic earnings per share are expected to be a loss of 0.0086 to 0.0128 yuan per share, compared to a profit of 0.0181 yuan per share in the previous year [1] Group 2 - The main reasons for the expected loss include intensified competition in the chemical equipment market and underperformance of the high-end equipment business segment, particularly the subsidiary Zhanghua Machinery [1] - The company has also made provisions for expected liabilities related to claims from minority shareholders, which has contributed to the decrease in net profit attributable to shareholders [1] - Despite the overall loss, the company aims to improve cost efficiency and asset quality, achieving a turnaround in net profit after deducting non-recurring gains and losses compared to the same period last year [1]

Core Viewpoint - Tianwo Technology (002564) announced an expected net profit loss of 7.4 million to 11 million yuan in the first half of 2025 [1] Company Summary - The company anticipates a significant net profit loss for the upcoming period, indicating potential challenges in financial performance [1]

[Current Period Performance Forecast](index=1&type=section&id=I.%20Current%20Period%20Performance%20Forecast) The company anticipates a net loss attributable to shareholders for the first half of 2025, contrasting with a profit in the prior year, while net profit after deducting non-recurring gains and losses is expected to turn profitable 2025 Semi-Annual Performance Forecast | Item | Current Reporting Period (Jan 1 - Jun 30, 2025) | Prior Year Period | | :--- | :--- | :--- | | **Net Profit Attributable to Shareholders** | Loss: CNY 7.40 million – CNY 11.00 million | Profit: CNY 15.51 million | | **Net Profit After Deducting Non-Recurring Gains and Losses** | Profit: CNY 1.35 million – CNY 2.00 million | Loss: CNY 29.27 million | | **Basic Earnings Per Share** | Loss: CNY 0.0086/share – CNY 0.0128/share | Profit: CNY 0.0181/share | - The company explicitly states that this performance forecast is a preliminary estimate by its finance department and has not been audited by an accounting firm[4](index=4&type=chunk) [Explanation of Performance Changes](index=1&type=section&id=III.%20Explanation%20of%20Performance%20Changes) The company attributes the net loss to intensified competition in the chemical equipment market, leading to lower-than-expected profits from its core subsidiary Zhanghuaji, and the provision for estimated liabilities related to claims from minority shareholders, despite which non-recurring net profit turned profitable through cost reduction and efficiency improvements - The primary reasons for the net loss attributable to shareholders include intensified competition in the chemical equipment market and the provision for estimated liabilities due to minority shareholder claims[5](index=5&type=chunk) - Compared to the prior year, the company achieved a turnaround in net profit after deducting non-recurring gains and losses through cost reduction, efficiency improvements, and strengthening asset quality[5](index=5&type=chunk) [Risk Warning and Other Related Disclosures](index=1&type=section&id=IV.%20Risk%20Warning%20and%20Other%20Related%20Disclosures) The company's primary risk stems from numerous litigation claims by minority shareholders, for which accounting treatment has been applied, and investors are cautioned that this preliminary forecast may be revised if significant changes occur in these claims, with final data subject to the official semi-annual report Minority Shareholder Litigation Claims | Claim Type | Quantity/Number of Persons | Amount Involved (CNY million) | | :--- | :--- | :--- | | Lawsuits with Court Notifications Received | 108 cases | 13.84 | | Other Forms of Claims (e.g., Lawyer's Letters) | 178 persons | 42.25 | - The company has performed appropriate accounting treatment for the aforementioned claims in accordance with accounting standards, noting that significant changes in claims before the semi-annual report disclosure may lead to adjustments in accounting treatment and information disclosure obligations[7](index=7&type=chunk)[8](index=8&type=chunk) - The company emphasizes that this performance forecast is a preliminary, unaudited estimate, and final financial data will be based on the forthcoming 2025 Semi-Annual Report, cautioning investors about investment risks[8](index=8&type=chunk)

Market Overview - The market experienced a strong upward trend, with the Shanghai Composite Index stabilizing above 3500 points. Real estate stocks surged in the afternoon, with several stocks such as Huaxia Happiness and Deep Deep Housing A hitting the daily limit. Major financial stocks continued to perform well, with the four major banks reaching historical highs. The photovoltaic sector also saw a rebound, particularly in the organic silicon segment, with multiple stocks hitting the daily limit. Overall, over 2800 stocks in the Shanghai and Shenzhen markets rose, with a total transaction volume of 1.51 trillion yuan [1]. Real Estate Sector - The real estate sector saw significant gains, with stocks like Sifang New Materials and Yucheng Development hitting the daily limit. The National Development and Reform Commission emphasized increasing investment in new urbanization, which catalyzed the market. Additionally, around 20 cities, including Chongqing and Shenyang, have supported and optimized the "commercial to public" policy this year [4][5]. - According to the China Index Academy, to alleviate insufficient effective demand, some cities may further relax purchase and loan restrictions, while also accelerating the construction of affordable housing and optimizing land supply structures to promote a stable and healthy real estate market [5]. Pharmaceutical Sector - The pharmaceutical sector remained active, with stocks like Saily Medical and Lianhuan Pharmaceutical hitting the daily limit. Merck announced a $10 billion acquisition of Verona Pharma to enhance its COPD treatment product line. The National Healthcare Security Administration and the National Health Commission issued measures to support the high-quality development of innovative drugs, which include 16 initiatives to strengthen support for innovative drug research and development [6][7]. - The trend of Chinese innovative drugs going global is expected to enhance profitability and market space, leading to improved industry valuation levels. The adjustment plan for the national medical insurance directory and commercial insurance innovative drug directory is anticipated to be implemented in November [8]. Hydrogen Energy Sector - The hydrogen energy sector showed strong performance, with stocks like Huaguang Huaneng and Tianwo Technology hitting the daily limit. The emphasis on developing hydrogen energy as part of a new energy system was highlighted during a recent inspection by the General Secretary in Shanxi [9][10]. - The strategic position of hydrogen energy has been established, with local policies supporting its development. The renewable energy green hydrogen production capacity is expected to reach over 400,000 tons by 2025 in the Sanbei region. The construction of hydrogen pipelines is also entering a capital-intensive phase, with major state-owned enterprises as primary investors [10]. Other Notable Sectors - Other sectors such as consumer goods and finance showed localized activity, while military and digital currency high-priced stocks experienced declines [11]. - The market is also witnessing a focus on performance as the mid-year reporting period approaches, with expectations for continued improvement in the performance of innovative drugs and their supply chains [8].

Group 1 - The A-share professional service sector experienced a rebound in the afternoon, indicating a positive market sentiment [1] - Guoyi Bidding achieved a consecutive increase of 30%, reflecting strong investor interest [1] - Guangzi International saw a rise of over 18%, showcasing significant growth in its stock performance [1] Group 2 - Debi Group increased by over 13%, contributing to the overall positive trend in the sector [1] - Other stocks such as Tianwo Technology, Zhongshi Consulting, New City, and Zhubo Technology also followed the upward trend, indicating a broad-based recovery in the professional services industry [1]